David Lynch

David’s capability and diverse skill set are evidenced by more than 18 years of leadership experience, driving commercial success and corporate growth objectives within start-up, turnaround, and blue-chip companies. Prior to joining Strateos, David held the role of VP of Business Development at Premier Research, a global clinical research organization, where he was tasked to develop, and implement commercial strategies to drive growth. Building and leading a team of business developers, he delivered exceptional growth doubling gross sales in less in 4 years. In the lab services segment, David was responsible for driving growth and market adoption within PPD’s lab division. In the medical device and diagnostic segment, David held commercial leadership positions that contributed to the successful divestiture of two companies. Earlier in his career, David was a consultant with Arthur D. Little, a top management consultancy.

David holds a Ph.D. in Microbiology and Infectious Diseases from the University of Pittsburgh, School of Public Health, and a BS from Syracuse University. David has several publications and has 1 issued patent (sole author) for the detection of RNA in tissue samples.